<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Protection of the blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) is correlated with improved outcome in <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="16393">Sphingosine</z:chebi> kinase (SphK)-directed production of <z:chebi fb="0" ids="37550">sphingosine-1-phosphate</z:chebi>, which we previously documented as being vital to preconditioning-induced <z:hpo ids='HP_0001297'>stroke</z:hpo> protection, mediates peripheral vascular integrity via junctional protein regulation </plain></SENT>
<SENT sid="2" pm="."><plain>We used a hypoxic preconditioning (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HPC</z:e>) model in adult <z:mp ids='MP_0002169'>wild-type</z:mp> and SphK2-null mice to examine the isoform-specific role of SphK2 signaling for ischemic tolerance to transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> and attendant <z:chebi fb="2" ids="33602">BBB</z:chebi> protection </plain></SENT>
<SENT sid="3" pm="."><plain>Reductions in <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and <z:chebi fb="2" ids="33602">BBB</z:chebi> permeability in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HPC</z:e>-treated mice were completely lost in SphK2-null mice </plain></SENT>
<SENT sid="4" pm="."><plain>Hypoxic preconditioning-induced attenuation of postischemic <z:chebi fb="2" ids="33602">BBB</z:chebi> disruption in <z:mp ids='MP_0002169'>wild types</z:mp>, evidenced by reduced extravascular immunoglobulin G intensity, suggests direct protection of <z:chebi fb="2" ids="33602">BBB</z:chebi> integrity </plain></SENT>
<SENT sid="5" pm="."><plain>Measurement of <z:chebi fb="2" ids="33602">BBB</z:chebi> junctional protein status in response to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HPC</z:e> revealed SphK2-dependent increases in <z:chebi fb="60" ids="29234">triton</z:chebi>-insoluble claudin-5 and VE-cadherin, which may serve to strengthen the <z:chebi fb="2" ids="33602">BBB</z:chebi> before <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Postischemic loss of VE-cadherin, occludin, and <z:e sem="disease" ids="C0019360" disease_type="Disease or Syndrome" abbrv="ZONA">zona</z:e> occludens-1 in SphK2-null mice with prior <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HPC</z:e> suggests that SphK2-dependent protection of these adherens and tight junction proteins is compulsory for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HPC</z:e> to establish a vasculoprotective phenotype </plain></SENT>
<SENT sid="7" pm="."><plain>Further elucidation of the mediators of this endogenous, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HPC</z:e>-activated <z:chebi fb="23" ids="18059">lipid</z:chebi> signaling pathway, and their role in protecting the ischemic <z:chebi fb="2" ids="33602">BBB</z:chebi>, may provide new therapeutic targets for cerebrovascular protection in <z:hpo ids='HP_0001297'>stroke</z:hpo> patients </plain></SENT>
</text></document>